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Background
At present the expression system of mammalian cells such
as CHO has been adopted as the conventional method to
produce antibody for pharmaceuticals. However a novel
method of producing antibody has been sought after as a
substitute for the costly production of antibody by mam-
malian cells. Therefore, we tried to construct a novel anti-
body production system by using methylotrophic yeast,
O. minuta.
Results
When human antibody genes were introduced in the
methylotrophic yeast O. minuta to produce an antibody,
the heavy chain of the antibody was partially degraded
(see Figure 1, lane 1). Peptide sequencing revealed that
degradation occurred in the CH1 region (see Figure 2). In
order to inhibit this degradation, the YPS1 gene coding
Aspartic protease attached to the plasma membrane, a
homologue of Saccharomyces cerevisiae, was cloned from
O. minuta, and we constructed the Δyps1 strain. As a result,
the Δyps1 strain repressed the partial degradation of the
antibody (see Figure 1, lane2).
from The 4th Recombinant Protein Production Meeting: a comparative view on host physiology
Barcelona, Spain. 21–23 September 2006
Published: 10 October 2006
Microbial Cell Factories 2006, 5(Suppl 1):P64 doi:10.1186/1475-2859-5-S1-P64
<supplement> <title> <p>The 4th Recombinant Protein Production Meeting: a comparative view on host physiology</p> </title> <sponsor> <note>The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting.</note> </sponsor> <note>Meeting abstracts – A single PDF containing all abstracts in this supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1475-2859-5-S1-full.pdf">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf</url> </supplement>
© 2006 Kuroda et al; licensee BioMed Central Ltd. 
Position of the partial degradation in the heavy chain on its CH1-hinge region pro uced by O. minuta YPS1 + strainFigure 2
Position of the partial degradation in the heavy chain on its 
CH1-hinge region produced by O. minuta YPS1 + strain. 
Arrows show the position of the degradation.
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Culture supernatant from the yeast O. minuta was subjected to Western analysis with HRP conjugated anti-human Fc anti-b dyFigure 1
Culture supernatant from the yeast O. minuta was subjected 
to Western analysis with HRP conjugated anti-human Fc anti-
body. Lane1: heavy chain secreted by YPS1+ strain. Lane2: 
heavy chain secreted by Δyps1 strain.
1  2 
Degraded  Heavy  Chain 
Heavy  ChainPage 1 of 2
(page number not for citation purposes)
Microbial Cell Factories 2006, 5(Suppl 1):P64Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




We constructed a protease-deficient strain and confirmed
the secretion of full-length antibody by yeast. Improving
the production of antibody should be a subject of further
research.
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